Oranogenesis Holdings (ORGO) PT Lowered to $10 at Credit Suisse
Tweet
Share
E-mailGet Alerts ORGO Hot Sheet
Price: $1.88 -1.57%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Matt Miksic lowered the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $10.00 (from $11.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
